Brickell Biotech Inc. Stock News

Brickell Biotech, Inc. (BBI) CEO Rob Brown on Q3 2021 Results - Earnings Call Transcript

Do these penny stocks have the potential to explode? The post Penny Stocks That Will Explode?

Brickell Biotech Inc (NASDAQ: BBI) has announced positive topline results from the Phase 3 pivotal Cardigan I and Cardigan II studies of sofpironium bromide gel for primary axillary hyperhidrosis (

Sofpironium bromide gel, 15% was generally well-tolerated

BOULDER, Colo., Sept. 17, 2021 (GLOBE NEWSWIRE) -- Brickell Biotech, Inc. (“Brickell”) (Nasdaq: BBI), a clinical-stage pharmaceutical company striving to transform patient lives by developing inno

Brickell Biotech Inc (NASDAQ: BBI) has entered into a definitive agreement with Voronoi Inc for exclusive, worldwide rights to therapeutics generated from a proprietary DYRK1A inhibitor platform. The

Dr. Luchi brings over 20 years of immunotherapeutic and drug development experience and will lead Brickell's clinical development strategy and medical affairs functions Dr. Luchi brings over 20 years

Expect to initiate Phase 1 clinical study of lead DYRK1A inhibitor program, BBI-02, a potential first-in-class oral treatment for autoimmune and inflammatory diseases, in 2022

Brickell (BBI) delivered earnings and revenue surprises of -45.45% and 51.00%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

Brickell Biotech, Inc. (BBI) CEO Robert Brown on Q2 2021 Results - Earnings Call Transcript

Brickell (BBI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

BOULDER, Colo., July 29, 2021 (GLOBE NEWSWIRE) -- Brickell Biotech, Inc. (“Brickell”) (Nasdaq: BBI), a clinical-stage pharmaceutical company focused on developing innovative and differentiated pre

Brickell Biotech (NASDAQ: BBI) shares are trading lower after the company announced a bought deal offering of common stock of $5 million, which was later increased to $7 million. Brickell Biotech is a

The stock price of Brickell Biotech Inc (NASDAQ: BBI) fell by over 20% pre-market. This is why it happened.

BOULDER, Colo., July 19, 2021 (GLOBE NEWSWIRE) -- Brickell Biotech, Inc. (Nasdaq: BBI) (the “Company” or “Brickell”), clinical-stage pharmaceutical company focused on developing innovative and